The stock, currently priced at ₹1,928.95, closed lower than its previous close of ₹1,983.10, marking a day change of -2.73%. Over the past week, Metropolis Healthcare’s stock return was -1.42%, contrasting with the Sensex’s positive 0.96% return. This trend extends over longer periods, with the stock showing a -6.51% return year-to-date against the Sensex’s 8.36%, and a -5.21% return over one year compared to the Sensex’s 9.48%. Despite these shorter-term figures, the stock has delivered a 33.33% return over three years, closely tracking the Sensex’s 37.31% over the same period.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- Recently turned profitable
- Strong business fundamentals
- Pre-breakout opportunity
Examining technical indicators, the weekly MACD presents a mildly bearish signal, while the monthly MACD remains bullish, indicating a divergence in momentum across timeframes. The Relative Strength Index (RSI) shows no definitive signal on both weekly and monthly charts, suggesting a lack of strong directional momentum. Bollinger Bands reveal a bearish stance on the weekly scale but a sideways pattern monthly, reinforcing the overall sideways trend in price action.
Moving averages on the daily chart indicate a mildly bullish trend, which contrasts with the weekly and monthly KST (Know Sure Thing) indicators that both show mildly bearish signals. The Dow Theory analysis aligns with this mixed picture, showing a mildly bearish trend weekly and no clear trend monthly. On-Balance Volume (OBV) data further supports this assessment, with no trend detected weekly and a mildly bearish indication monthly.
Price volatility remains contained within the 52-week range of ₹1,383.70 to ₹2,259.30, with the day’s high at ₹1,983.80 and low at ₹1,922.10. This range-bound movement aligns with the sideways technical trend, reflecting a period of consolidation for Metropolis Healthcare.
Considering Metropolis Healthcare ? Wait! SwitchER has found potentially better options in Healthcare Services and beyond. Compare this small-cap with top-rated alternatives now!
- Better options discovered
- Healthcare Services + beyond scope
- Top-rated alternatives ready
Metropolis Healthcare’s market capitalisation grade stands at 3, reflecting its mid-tier valuation within the healthcare services sector. The recent adjustment in its mojo score to 55.0, with a grade change dated 11 August 2025, indicates a revision in its technical evaluation from a previous sell stance to a hold position. This change was triggered by technical parameters on 19 November 2025, underscoring the evolving market perception of the stock’s momentum.
Investors analysing Metropolis Healthcare should consider the mixed technical signals and sideways price action as indicative of a consolidation phase. The divergence between short-term and long-term indicators suggests that while immediate momentum may be subdued, the broader trend retains elements of strength. Comparisons with benchmark indices such as the Sensex highlight the stock’s relative underperformance in recent periods, which may influence portfolio allocation decisions within the healthcare services sector.
Overall, the technical parameter changes for Metropolis Healthcare reflect a complex interplay of bullish and bearish signals across multiple timeframes. This nuanced momentum shift warrants close monitoring for any emerging trends that could influence future price direction.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
